Apart from highlighting key aspects of India’s fight against the novel coronavirus, the book titled ‘Till We Win: India’s Fight Against The Covid-19 Pandemic’ talks in great detail about a vaccine and how will it be administered.
Healthy adults in India with no underlying conditions might have to wait till 2022 to get a coronavirus vaccine, according to a new book. Co-authored by AIIMS Director Dr Randeep Guleria, vaccine researcher and virologist Dr Gagandeep Kang, and health systems expert Dr Chandrakant Lahariya, the book titled ‘Till We Win: India’s Fight Against The Covid-19 Pandemic’ will hit the stands on December 10.
In the book, top experts reiterate the claim made by several researchers that some Covid-19 vaccines are likely to be available by early 2021. One of the co-authors, Dr Gagandeep Kang had told India Today earlier this month that the University of Oxford and AstraZeneca are close to submitting the clinical efficacy data of their coronavirus vaccine candidate.
While reiterating Dr Kang’s speculation, the book goes on to suggest that 20 per cent of India’s population will be vaccinated in the first phase of an inoculation drive. Healthcare workers, essential workers, the elderly and those with comorbidities are likely to receive the vaccine first.
This would also mean that a healthy adult with no underlying health conditions is likely to receive a coronavirus vaccine “likely in 2020”, according to the book.
The authors also suggest that it will take at least “two to three years” before a sufficient number of vaccine doses are made available to all those in need across India.
“If the goal is to prevent maximum deaths, vaccinating health workers and the elderly makes sense in the first phase. However, if the goal is to prevent transmission, then vaccinating younger people who interact more with others is the way to consider,” news agency PTI said quoting an excerpt from the unreleased book.
Apart from stating that most of India is “still far” from herd immunity, the book adds that even an “imperfect vaccine” for Covid-19 will go a long way in protecting a large part of the population. The book also says that priority should be given to population groups on the basis of the “purpose for which the vaccine is used”.